Can beta-blockers be continued in patients requiring inotropic therapy?

Although beta blockers are considered a fundamental therapy for patients with heart failure (HF), questions remain on how to manage them these medications in patients presenting with decompensation requiring intravenous inotropic therapy. In this post, we will provide some insights on managing the chronic beta blockade and intravenous inotropic therapy when used concomitantly in a decompensated HF patient.

Obstructive sleep apnea screening: what every pharmacist should know

Obstructive sleep apnea (OSA) is a risk factor for several cardiac conditions and is a common chronic condition. It is important for providers to screen patients for OSA so they can undergo diagnostic testing, and potentially treatment. This piece will review the risk factors for OSA, screening and the association with cardiac conditions such as heart failure, atrial fibrillation and bradycardia.